Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis

Forner, 2018, Hepatocellular carcinoma, The Lancet, 391, 1301, 10.1016/S0140-6736(18)30010-2 Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423 McGlynn, 2021, Epidemiology of hepatocellular carcinoma, Hepatology, 73, 4, 10.1002/hep.31288 Chalasani, 2018, The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases, Hepatology, 67, 328, 10.1002/hep.29367 Nderitu, 2017, The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: a study in the Swedish AMORIS cohort: association between individual MetS components, PLC and Cirrhosis, Int J Cancer, 141, 1148, 10.1002/ijc.30818 Piccinin, 2019, Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators, Nat Rev Gastroenterol Hepatol, 16, 160, 10.1038/s41575-018-0089-3 Mittal, 2016, Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 14, 124, 10.1016/j.cgh.2015.07.019 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Rudalska, 2021, LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer, Nat Cancer, 2, 201, 10.1038/s43018-020-00168-3 Menendez, 2007, Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis, Nat Rev Cancer, 7, 763, 10.1038/nrc2222 Xie, 2022, Chronic activation of LXRα sensitizes mice to hepatocellular carcinoma, Hepatol Commun, 6, 1123, 10.1002/hep4.1880 Reed, 1970, Mode of action of hypoglycemic agents. 3. Studies on 5-methoxy indole-2-carboxylic acid and quinaldic acid, J Biol Chem, 245, 5297, 10.1016/S0021-9258(18)62754-1 Piccinin, 2018, Hepatic peroxisome proliferator-activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice, Hepatology, 67, 884, 10.1002/hep.29484 Triki, 2020, mTOR signaling and SREBP activity increase FADS2 expression and can activate sapienate biosynthesis, Cell Rep, 31, 10.1016/j.celrep.2020.107806 Marra, 2018, Lipotoxicity and the gut-liver axis in NASH pathogenesis, J Hepatol, 68, 280, 10.1016/j.jhep.2017.11.014 Saponaro, 2022, Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals., Liver International, 42, 2418, 10.1111/liv.15377 Mackness, 1995, HDL, its enzymes and its potential to influence lipid peroxidation, Atherosclerosis, 115, 243, 10.1016/0021-9150(94)05524-M Ahn, 2009, Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer, Cancer Epidemiol Biomarkers Prev, 18, 2814, 10.1158/1055-9965.EPI-08-1248 Härdfeldt, 2022, Abdominal obesity negatively influences key metrics of reverse cholesterol transport, Biochim Biophys Acta Mol Cel Biol Lipids, 1867 Zhong, 2020, HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies, Eur J Prev Cardiolog, 27, 1187, 10.1177/2047487320914756 Benn, 2016, High body mass index and cancer risk—a Mendelian randomisation study, Eur J Epidemiol, 31, 879, 10.1007/s10654-016-0147-5 Zhao, 2014, HDL cholesterol and cancer risk among patients with type 2 diabetes, Diabetes Care, 37, 3196, 10.2337/dc14-0523 De Matteis, 2021, AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects, Sci Rep, 11, 10.1038/s41598-021-94277-3 Pugh, 1973, Transection of the oesophagus for bleeding oesophageal varices, Br J Surg, 60, 646, 10.1002/bjs.1800600817 Kim, 2008, Hyponatremia and mortality among patients on the liver-transplant waiting list, N Engl J Med, 359, 1018, 10.1056/NEJMoa0801209 meld_na [Internet]. Available from: https://optn.transplant.hrsa.gov/media/1575/policynotice_20151101.pdf. Zhao, 2021, Dietary fats, serum cholesterol and liver cancer risk: a systematic review and meta-analysis of prospective studies, Cancers (Basel), 13, 1580, 10.3390/cancers13071580 Sun, 2021, Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: a population-based prospective study, Medicine (Baltimore), 100 Han, 2017, Blood glucose concentration and risk of liver cancer: systematic review and meta-analysis of prospective studies, Oncotarget, 8, 50164, 10.18632/oncotarget.16816 Yi, 2021, Effect of vitamin D deficiency on liver cancer risk: a systematic review and meta-analysis, Asian Pac J Cancer Prev, 22, 991, 10.31557/APJCP.2021.22.4.991 Desterke, 2019, Lipid related genes altered in NASH connect inflammation in liver pathogenesis progression to HCC: a canonical pathway, Int J Mol Sci, 20, E5594, 10.3390/ijms20225594 Rao, 2021, Role of high-density lipoprotein cholesterol (HDL-C) as a clinical predictor of decompensation in patients with chronic liver disease (CLD), Int J Hepatol, 2021 Akkiz, 2021, Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV, J Transl Sci, 7 Tian, 2017, A new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resections, Lipids Health Dis, 16, 123, 10.1186/s12944-017-0509-3 Jiang, 2016, The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma, J Cancer, 7, 626 Pirro, 2018, High density lipoprotein cholesterol and cancer: marker or causative?, Prog Lipid Res, 71, 54, 10.1016/j.plipres.2018.06.001 Long, 2018, Tumor LXR expression is a prognostic marker for patients with hepatocellular carcinoma, Pathol Oncol Res, 24, 339, 10.1007/s12253-017-0249-8 Lo Sasso, 2010, Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes, Hepatology, 51, 1334, 10.1002/hep.23436 Lo Sasso, 2013, Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice, Gastroenterology, 144, 1497, 10.1053/j.gastro.2013.02.005 Crudele, 2021, Visceral adiposity and cancer: role in pathogenesis and prognosis, Nutrients, 13, 2101, 10.3390/nu13062101 Masuzaki, 2016, NAFLD as a risk factor for HCC: new rules of engagement?, Hepatol Int, 10, 533, 10.1007/s12072-016-9731-8 Bovenga, 2015, Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer, Cell Metab, 21, 517, 10.1016/j.cmet.2015.03.002 Anstee, 2019, From NASH to HCC: current concepts and future challenges, Nat Rev Gastroenterol Hepatol, 16, 411, 10.1038/s41575-019-0145-7 Pascual, 2017, Targeting metastasis-initiating cells through the fatty acid receptor CD36, Nature, 541, 41, 10.1038/nature20791 Chen, 2018, An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer, Nat Genet, 50, 206, 10.1038/s41588-017-0027-2 Ioannou, 2022, Pcsk9 deletion promotes murine nonalcoholic steatohepatitis and hepatic carcinogenesis: role of cholesterol, Hepatol Commun, 6, 780, 10.1002/hep4.1858 Zhang, 2021, Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites, Gut, 70, 761, 10.1136/gutjnl-2019-319664 El-Sharkawy, 2020, Vitamin D signaling in inflammation and cancer: molecular mechanisms and therapeutic implications, Molecules, 25, E3219, 10.3390/molecules25143219 Mainous, 2005, Iron, lipids, and risk of cancer in the Framingham offspring cohort, Am J Epidemiol, 161, 1115, 10.1093/aje/kwi131